Importantly, inhibition of the expression or activation of PGAM1 by shRNA or small molecule inhibitors suppresses glycolysis and anabolic biosynthesis, and reduces cell proliferation as well as tumor growth (Huang et al, 2019; Wen et al, 2019). Here, PGAM1 is linked to neoplasm.